Edition:
United States

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.10USD
15 Dec 2017
Change (% chg)

$-0.25 (-4.67%)
Prev Close
$5.35
Open
$5.42
Day's High
$5.42
Day's Low
$4.77
Volume
389,331
Avg. Vol
156,949
52-wk High
$14.09
52-wk Low
$4.77

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
FY 2015 Dec '15 3.77 -23.706
Sep '15 0.00 -4.154
Jun '15 0.00 -2.966
Mar '15 0.00 -4.981
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 1.40 1.80 1.00 0.57
Quarter Ending Mar-18 4 1.62 2.30 1.00 --
Year Ending Dec-17 6 5.60 6.00 5.20 3.54
Year Ending Dec-18 6 5.67 9.50 2.90 3.70
Earnings (per share)
Quarter Ending Dec-17 6 -0.57 -0.48 -0.62 -0.59
Quarter Ending Mar-18 4 -0.57 -0.48 -0.63 --
Year Ending Dec-17 5 -2.61 -2.46 -3.06 -2.74
Year Ending Dec-18 6 -2.31 -1.85 -2.86 -12.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) 28.77 122.78 5.95
Price to Book (MRQ) 1.81 23.45 5.68
Price to Tangible Book (MRQ) 1.82 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 67.67 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 51.18 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -18.11 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -20.24 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -28.97 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 7.22 5.62 3.56
LT Debt to Equity (MRQ) 0.22 16.22 13.38
Total Debt to Equity (MRQ) 0.22 18.71 19.38
Interest Coverage (TTM) -2.47 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -206.49 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -1,012.78 -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -1,018.25 -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -1,025.49 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -1,034.46 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 110,237 22,314,532 851,801,741
Net Income/Employee (TTM) -1,140,356 -1,997,855 99,542,701
Receivable Turnover (TTM) 1.01 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.06 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -65.57 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -77.01 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -77.24 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.07 -15.26 19 94
13 Week -25.66 -30.53 18 75
26 Week -44.57 -49.59 14 59
52 Week -0.97 -16.28 52 58
YTD -14.43 -28.40 41 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.69%
# of Holders: 46
Total Shares Held: 24,835,415
3 Mo. Net Change: 4,868,743
# New Positions: 25
# Closed Positions: 8
# Increased Positions: 38
# Reduced Positions: 11
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.